Delivery Order SPE2DP25D0002-SPE2DP26F1837
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $4.41 million to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 7, 2026, for Japanese encephalitis vaccine (IXIARO), with final delivery expected by February 26, 2026. The contract carries firm fixed-price terms with no set-aside designation. Valneva USA, a Bethesda, Maryland-based subsidiary of French-based Valneva SE, is the sole prime contractor on this delivery order, which will be...
- Valneva USA, Inc., a specialty vaccine manufacturer headquartered in Bethesda, Maryland and subsidiary of French-based Valneva SE, was awarded a delivery order valued at $8.25 million on October 23, 2025, for Japanese encephalitis vaccine (IXIARO) to support the Medical Supply Chain program within the Defense Department. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents performance at Valneva USA's Bethesda facility and carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded Valneva USA, Inc. a $2.9 million firm fixed-price delivery order for Japanese encephalitis vaccine (IXIARO) on January 22, 2026, with ultimate completion by May 27, 2026. The vaccine will be delivered to Bethesda, Maryland. Valneva USA, Inc., a Bethesda-based subsidiary of French-based Valneva SE, is a specialty vaccine manufacturer that serves as a critical supplier of vaccines and pharmaceutical products to multiple federal agencies....
- This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the specialty vaccine company Valneva SE. The $12,790,400.00 contract is for the delivery of the Japanese encephalitis vaccine IXIARO, with a completion date of March 13, 2024. This award is likely associated with Valneva USA's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Defense...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract (SPE2DP23D0004) to Valneva USA, Inc., doing business as Intercell USA Inc., for the supply of the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $3,203,200.00 and a completion date of June 5, 2024. This order is part of a larger $48,025,600 indefinite-delivery/indefinite-quantity (IDIQ) contract awarded to Valneva USA in 2023, which supports the Department...
- Valneva USA, Inc. (doing business as Intercell USA Inc.) was awarded a $710,457 firm fixed-price delivery order by the Department of Veterans Affairs, Veterans Integrated Service Network 12, on November 1, 2025, for the supply of Japanese Encephalitis Virus Vaccine IXIARO. The contract is scheduled for completion by September 30, 2026, with performance taking place in Bethesda, Maryland. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) to provide Japanese encephalitis vaccines. The contract has a potential value of $10,199,266.00 and a completion date of May 18, 2018. Valneva USA, a subsidiary of Valneva SE, is the prime contractor and has no set-aside designation. The contract is part of Valneva USA's existing indefinite-delivery/indefinite-quantity (ID/IQ)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc. (a subsidiary of the French vaccine company Valneva SE) to supply the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $48,000.00 and a completion date of December 31, 2025. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $48,025,600, to support the Department of Defense's medical countermeasures...
- This is a $6,406,400.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., a subsidiary of the specialty vaccine company Valneva SE. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO, with a completion date of January 19, 2024. Valneva USA has held similar indefinite delivery/indefinite quantity contracts and blanket purchase agreements with the Defense Logistics Agency and other federal agencies...
- SPE2DP25D0002Indefinite Delivery Contract
- SPE2DP25D0002-SPE2DP26F1837Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $5.15M firm fixed-price delivery order to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 22, 2026, for Japanese encephalitis vaccine (IXIARO), with an ultimate completion date of April 27, 2026. The award carries no set-aside designation and represents a child contract issued against one of Valneva USA's existing indefinite delivery vehicles with the Defense Logistics Agency. Valneva USA, a Bethesda, Maryland-based subsidiary of French-based Valneva SE, serves as a critical federal supplier of specialty vaccines with particular expertise in Japanese encephalitis vaccination to support Department of Defense medical readiness and public health requirements. This delivery order draws from Valneva USA's established relationship with the Defense Logistics Agency, which has awarded the company multiple indefinite delivery contracts for pharmaceutical supply totaling approximately $97.3M across active vehicles. The contractor maintains no subcontractors on this award and will perform all work at its Bethesda, Maryland facility. The contract supports the federal government's medical countermeasures program and aligns with the Department of Defense's personnel vaccination initiatives, leveraging firm fixed-price delivery structures to efficiently procure critical vaccine supplies across federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1m | 1/21/26 |